Benazepril hydrochloride and hydrochlorothiazide (Ranbaxy Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Benazepril hydrochloride and hydrochlorothiazide drug offered from Ranbaxy Pharmaceuticals Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ranbaxy Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Benazepril hydrochloride and hydrochlorothiazide |
| SUBSTANCE NAME: | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2006-04-10 |
| END MARKETING DATE: | 0000-00-00 |
Benazepril hydrochloride and hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Benazepril hydrochloride and hydrochlorothiazide from Ranbaxy Pharmaceuticals Inc. |
| LABELER NAME: | Ranbaxy Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 6.25(mg/1; mg/1) |
| START MARKETING DATE: | 2006-04-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63304-154_ff91020b-46cc-4065-bff1-83b5263a2193 |
| PRODUCT NDC: | 63304-154 |
| APPLICATION NUMBER: | ANDA077483 |
Other BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
